Trials / Completed
CompletedNCT03811288
An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes
A Non-interventional Cross-sectional Study to Capture the Prevalence of Cardiovascular Disease in Patients With Type 2 Diabetes - an International Observation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,548 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than prescribed to them by their doctor. Participants' participation will be one day/one visit at their doctor. The study will last for about 6 months in total.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions. |
Timeline
- Start date
- 2018-12-10
- Primary completion
- 2019-09-30
- Completion
- 2019-09-30
- First posted
- 2019-01-22
- Last updated
- 2020-06-09
Locations
164 sites across 10 countries: Algeria, Argentina, Australia, Brazil, China, Israel, Japan, Mexico, Saudi Arabia, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03811288. Inclusion in this directory is not an endorsement.